Laurie Myers

Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS.

Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS.

Part of P.&R. The company is based in Parsippany, NJ. The website is intended for use by US residents only. S.p.A, Fidia Pharma USA, Inc. is a pharmaceutical company. The company's product portfolio includes hyaluronic acid-based viscosupplement products. Fidia is committed to compliantly assisting its customers to ensure a smooth transition from WAC-based to ASP-based reimbursement. Fidia Pharma USA is a wholly owned subsidiary of Fidia Farmaceutici S.p.A, which was founded in 1946.